Robotic prostatectomy surgery has been found to be effective and safe for treating obese men who are fighting against prostate cancer.
Research has revealed that obese men are at increased risk of developing prostate cancer, and their obesity affects their recovery from treatment. Excess weight and obesity lead to health issues within the human body. A high BMI affects diagnosis and treatment.
The Vice Chairman of the Department of Urology at The Mount Sinai Medical Center, Dr. David Samadi, stated that the U.S. population continued to gain weight despite efforts. Dr. Samadi is also the Chief of Robotics and Minimally Invasive Surgery at the center.
Research published in the Annals of Oncology has found that in men, for every 5-point BMI increase there was a 9% increased risk of developing prostate cancer. When a man had the same BMI growth rate, the data showed that there was a 6% decreased risk of development of another form of prostate cancer with less aggressive quality.
The Journal of Obesity had earlier reported that there was increased screening for prostate cancer in obese men. Dr. Samadi, lauded the high vigilance among physicians for prostate cancer PSA testing.
A study released at the 2011 annual meeting of the American Urological Association revealed that in overweight patients their prostate cancer advanced three times faster than persons with normal weight. Obese men require careful consideration of the type of treatment to be given. Surgical complications, more time for surgery and increased blood losses are critical concerns. Obesity plays a part in determining in outcomes of prostate cancer surgery.
Optimizing general wellness, eating better, being active and having a healthier weight can help reduce the risk in outcomes of prostate cancer surgery.
Source: http://www.roboticoncology.com/